Designing and Conducting Gender Sex and Health Research

Designing and Conducting Gender  Sex  and Health Research
Author: John L. Oliffe,Lorraine Greaves
Publsiher: SAGE
Total Pages: 280
Release: 2011-04-18
ISBN 10: 1452236550
ISBN 13: 9781452236551
Language: EN, FR, DE, ES & NL

Designing and Conducting Gender Sex and Health Research Book Review:

This book provides the first resource dedicated to critically examining gender and sex in study designs, methods, and analysis in health research. In order to produce ethical, accurate, and effective research findings it is vital to integrate both sex (biological characteristics) and gender (socially constructed factors) into any health study. This book draws attention to some of the methodological complexities in this enterprise and offers ways to thoughtfully address these by drawing on empirical examples across a range of topics and disciplines.

Setting priorities for publicly funded research

Setting priorities for publicly funded research
Author: Great Britain: Parliament: House of Lords: Science and Technology Committee
Publsiher: The Stationery Office
Total Pages: 509
Release: 2010-04-14
ISBN 10: 9780108472404
ISBN 13: 010847240X
Language: EN, FR, DE, ES & NL

Setting priorities for publicly funded research Book Review:

In its report into how priorities are set for publicly funded research, the Science and Technology Committee calls on the Government to make a clear and unambiguous statement setting out their research funding commitments and the periods of time over which those commitments apply.

Translational Medicine Tools And Techniques

Translational Medicine  Tools And Techniques
Author: Aamir Shahzad
Publsiher: Academic Press
Total Pages: 196
Release: 2015-11-24
ISBN 10: 0128034947
ISBN 13: 9780128034941
Language: EN, FR, DE, ES & NL

Translational Medicine Tools And Techniques Book Review:

Translational Medicine: Tools and Techniques provides a standardized path from basic research to the clinic and brings together various policy and practice issues to simplify the broad interdisciplinary field. With discussions from academic and industry leaders at international institutions who have successfully implemented translational medicine techniques and tools in various settings, readers will be guided through implementation strategies relevant to their own needs and institutions. The book also addresses regulatory processes in USA, EU, Japan and China. By providing details on omics sciences techniques, biomarkers, data mining and management approaches, case reports from industry, and tools to assess the value of different technologies and techniques, this book is the first to provide a user-friendly go-to guide for key opinion leaders (KOLs), industry administrators, faculty members, clinicians, researchers, and students interested in translational medicine. Includes detailed and standardized information about the techniques and tools used in translational medicine Provides specific industry case scenarios Explains how to use translational medicine tools and techniques to plan and improve infrastructures and capabilities while reducing cost and optimizing resources

Translational Medicine What Why and How

Translational Medicine   What  Why and How
Author: Barbara Alving,Kerong Dai,Samuel H. H. Chan
Publsiher: Karger Medical and Scientific Publishers
Total Pages: 126
Release: 2012-12-01
ISBN 10: 3318022845
ISBN 13: 9783318022841
Language: EN, FR, DE, ES & NL

Translational Medicine What Why and How Book Review:

This book is the first to provide an aerial view, as well as detailed information, on 'how' activities in translational medicine are under development in countries such as the USA, China, the UK, and Taiwan. Institutions in each country are training investigators to work as sophisticated interdisciplinary teams. Investigators from 11 US academic health centers explain how they are incentivizing collaborations through pilot project programs, forming partnerships with business schools to promote efficient management of basic and clinical research, creating ethical, high- value public-private (industry) partnerships, improving efficiency with utilization of informatics, and engaging the community in research. The essential role of evaluation is explained in a clear and concise manner. The readers will also learn about the role of private funding in Taiwan and the vision of the government in China in developing multiple translational research centers. The UK is developing methodical approaches to patient needs across their lifespans; ongoing innovation is encouraged through incubator programs. With the emphasis on open innovation and sharing, the concepts and practice of translational medicine are spreading rapidly on an international scale.

Clinical and Translational Science

Clinical and Translational Science
Author: David Robertson,Gordon H. Williams
Publsiher: Academic Press
Total Pages: 808
Release: 2016-11-25
ISBN 10: 012802111X
ISBN 13: 9780128021118
Language: EN, FR, DE, ES & NL

Clinical and Translational Science Book Review:

Clinical and Translational Science: Principles of Human Research, Second Edition, is the most authoritative and timely resource for the broad range of investigators taking on the challenge of clinical and translational science, a field that is devoted to investigating human health and disease, interventions, and outcomes for the purposes of developing new treatment approaches, devices, and modalities to improve health. This updated second edition has been prepared with an international perspective, beginning with fundamental principles, experimental design, epidemiology, traditional and new biostatistical approaches, and investigative tools. It presents complete instruction and guidance from fundamental principles, approaches, and infrastructure, especially for human genetics and genomics, human pharmacology, research in special populations, the societal context of human research, and the future of human research. The book moves on to discuss legal, social, and ethical issues, and concludes with a discussion of future prospects, providing readers with a comprehensive view of this rapidly developing area of science. Introduces novel physiological and therapeutic strategies for engaging the fastest growing scientific field in both the private sector and academic medicine Brings insights from international leaders into the discipline of clinical and translational science Addresses drug discovery, drug repurposing and development, innovative and improved approaches to go/no-go decisions in drug development, and traditional and innovative clinical trial designs

Recent Advances in Molecular and Translational Medicine Updates in Precision Medicine

Recent Advances in Molecular and Translational Medicine  Updates in Precision Medicine
Author: Somchai Chutipongtanate
Publsiher: Bentham Science Publishers
Total Pages: 260
Release: 2021-12-13
ISBN 10: 9815036769
ISBN 13: 9789815036763
Language: EN, FR, DE, ES & NL

Recent Advances in Molecular and Translational Medicine Updates in Precision Medicine Book Review:

Precision medicine is a disruptive innovation with a fast-evolving pace in the healthcare ecosystem. Precision medicine enables precise diagnosis and targeted treatment by considering individual variability in the abnormalities of causative genes and molecular drivers behind biochemical mechanisms. A vast amount of data created by advanced omics technologies is a foundation of precision medicine’s success, and the implications of the findings from these technologies can potentially improve clinical outcomes. Recent Advances in Molecular and Translational Medicine: Updates in Precision Medicine presents essential information of molecular and translational research in precision medicine, with a specific focus on pediatrics. This book provides an accessible introduction to omics technologies, gives a detailed explanation of bioinformatics workflows to interpret high-throughput omics profiles for molecular diagnosis, and collects some of the cutting-edge research for precise therapeutics. Contributions to the book have been provided by experts in biomedical engineering and clinical practice, thus, bringing an informed perspective to the reader on each topic. The book is a valuable resource for postgraduate students, researchers, data scientists and clinicians interested in precision medicine, as well as researchers in the field of genetics and pediatrics who are interested in understanding the role of precision medicine in clinical practice.


Author: Great Britain: Parliament: House of Commons: Science and Technology Committee
Publsiher: The Stationery Office
Total Pages: 236
Release: 2010-03-25
ISBN 10: 9780215545268
ISBN 13: 0215545265
Language: EN, FR, DE, ES & NL

Bioengineering Book Review:

This report finds that the UK has an excellent research base but is still failing to maximise its potential by translating research into wealth and health. The road to economic recovery will depend, in part, on exploitation of the UK's research base, which in turn requires efficient translation to generate returns on investments. Some areas of bioengineering, such as stem cells, have clearly benefited from strong Government leadership and support, backed up by generous levels of funding from both the public and private sectors. Others, such as genetically modified (GM) crops, are less well supported and funded. This is curious when GM crops are considered by the Government to be safe and offer potential benefits. GM crops are certainly the poor cousin in the bioengineering family, and we strongly urge the Government to signal its support for GM crops as well as improving the regulatory situation in Europe. Regulation of bioengineering is complex and researchers have found that regulations inhibit research and translation, either because of regulatory complexity (stem cells) or a flawed operation of the regulatory process (GM crops). There are good indications that the UK is learning from past experiences in bioengineering when handling new emerging technologies, such as synthetic biology. The Government and Research Councils have recognised the value of synthetic biology early, and are providing funding. The Committee is also concerned that while research is well funded there is not enough forethought about synthetic biology translation, for example developing DNA synthesis capability, which would provide the UK with an excellent opportunity to get ahead internationally. If this is not addressed, synthetic biology runs the risk of becoming yet another story of the UK failing to capitalise on a strong research base and falling behind internationally.

Issues in Prevention Diagnostics Screening Statistics and Testing 2011 Edition

Issues in Prevention  Diagnostics  Screening  Statistics  and Testing  2011 Edition
Author: Anonim
Publsiher: ScholarlyEditions
Total Pages: 333
Release: 2012-01-09
ISBN 10: 1464967199
ISBN 13: 9781464967191
Language: EN, FR, DE, ES & NL

Issues in Prevention Diagnostics Screening Statistics and Testing 2011 Edition Book Review:

Issues in Prevention, Diagnostics, Screening, Statistics, and Testing: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Prevention, Diagnostics, Screening, Statistics, and Testing. The editors have built Issues in Prevention, Diagnostics, Screening, Statistics, and Testing: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Prevention, Diagnostics, Screening, Statistics, and Testing in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Prevention, Diagnostics, Screening, Statistics, and Testing: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at

Translational Medicine

Translational Medicine
Author: James Mittra,Christopher-Paul Milne
Publsiher: CRC Press
Total Pages: 294
Release: 2016-04-19
ISBN 10: 9814364843
ISBN 13: 9789814364843
Language: EN, FR, DE, ES & NL

Translational Medicine Book Review:

This book brings together a range of academic, industry and practitioner perspectives on translational medicine (TM). It enhances conceptual and practical understanding of the emergence and progress of the field and its potential impact on basic research, therapeutic development, and institutional infrastructure. In recognition of the various implications TM has for public health policy and commercial innovation, the book addresses the major systemic aspects of the field. The contributors explore the dynamic interactions and key challenges in translating new science into viable therapies for the clinic, which includes recognizing the importance of social, commercial, and regulatory environments in addition to good science.

Evaluating and Conducting Research in Audiology

Evaluating and Conducting Research in Audiology
Author: Vinaya Manchaiah, Eldré Beukes, Ross J. Roeser
Publsiher: Plural Publishing
Total Pages: 400
Release: 2021-02-04
ISBN 10: 1635502012
ISBN 13: 9781635502015
Language: EN, FR, DE, ES & NL

Evaluating and Conducting Research in Audiology Book Review:

Evaluating and Conducting Research in Audiology is the first research methods textbook that is specific to the field of audiology and designed to serve as an academic textbook for audiology graduate students. This text can also be accessible for audiology practitioners who are interested in clinical and applied research. The comprehensive coverage includes materials for multiple courses within audiology degree programs, including research methods, analysis of professional literature, evidence-based practice, and capstone research projects. Classroom tested, and written by authors who have extensive backgrounds in publishing and editing, this text provides knowledge that is required in evaluating, conducting, and disseminating research. The book is separated into three sections: (a) research methods; (b) evidence-based practice; and (c) conducting and disseminating research. Together, these sections provide a detailed coverage of the research methods that are relevant to conducting research, particularly in the field of Audiology. Key Features: * Learning outcomes at the beginning of each chapter * End of chapter reviews including key points and study questions * Audiology-specific examples, research methods, and study designs * “Golden Nugget” boxes throughout the book containing valuable information related to the critical concepts * In-depth discussion of qualitative research methods, survey research methods, and systematic reviews to motivate students and early career researchers to consider these methodologies in their research

Clinical Trial Design Challenges in Mood Disorders

Clinical Trial Design Challenges in Mood Disorders
Author: Mauricio Tohen,Charles Bowden,Andrew A. Nierenberg,John Geddes
Publsiher: Academic Press
Total Pages: 192
Release: 2015-01-24
ISBN 10: 0124051766
ISBN 13: 9780124051768
Language: EN, FR, DE, ES & NL

Clinical Trial Design Challenges in Mood Disorders Book Review:

Poor clinical trial designs result in failed studies wasting research funds and limiting the advancement of cures for disorders. Clinical Trial Design Challenges in Mood Disorders outlines classic problems researchers face in designing clinical trials and discusses how best to address them for the most definitive and generalizable results. Traditional trial designs are included as well as novel analytic techniques. The book examines information on high placebo response, the generalizability of studies conducted in the developing world, the duration of maintenance studies, and the application of findings into clinical practice. With representation from contributors throughout the world and from academia, industry, regulatory agencies, and advocacy groups, this book will contribute toward improved clinical trial design and valid, precise, and reliable answers about what works better and faster for patients. Summarizes common trial design problems and their solutions Encompasses funding, subject selection, regulatory issues and more Identifies best practices for definitive and generalizable results Includes traditional trial designs and novel analytic techniques Represents academia, industry, regulatory agencies, and advocacy groups

Integrating Clinical Research into Epidemic Response

Integrating Clinical Research into Epidemic Response
Author: National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Global Health,Committee on Clinical Trials During the 2014-2015 Ebola Outbreak
Publsiher: National Academies Press
Total Pages: 342
Release: 2017-06-26
ISBN 10: 0309457793
ISBN 13: 9780309457798
Language: EN, FR, DE, ES & NL

Integrating Clinical Research into Epidemic Response Book Review:

The 2014â€"2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Republic of Congo (then Zaire) and South Sudan (then Sudan). However, because all Ebola outbreaks prior to that in West Africa in 2014â€"2015 were relatively isolated and of short duration, little was known about how to best manage patients to improve survival, and there were no approved therapeutics or vaccines. When the World Heath Organization declared the 2014-2015 epidemic a public health emergency of international concern in August 2014, several teams began conducting formal clinical trials in the Ebola affected countries during the outbreak. Integrating Clinical Research into Epidemic Response: The Ebola Experience assesses the value of the clinical trials held during the 2014â€"2015 epidemic and makes recommendations about how the conduct of trials could be improved in the context of a future international emerging or re-emerging infectious disease events.

Translational Medicine

Translational Medicine
Author: Dennis Cosmatos,Shein-Chung Chow
Publsiher: CRC Press
Total Pages: 224
Release: 2008-12-17
ISBN 10: 9781584888734
ISBN 13: 1584888733
Language: EN, FR, DE, ES & NL

Translational Medicine Book Review:

Examines Critical Decisions for Transitioning Lab Science to a Clinical Setting The development of therapeutic pharmaceutical compounds is becoming more expensive, and the success rates for getting such treatments approved for marketing and to the patients is decreasing. As a result, translational medicine (TM) is becoming increasingly important in the healthcare industry – a means of maximizing the consideration and use of information collected as compounds transition from initial lab discovery, through pre-clinical testing, early clinical trials, and late confirmatory studies that lead to regulatory approval of drug release to patients. Translational Medicine: Strategies and Statistical Methods suggests a process for transitioning from the initial lab discovery to the patient’s bedside with minimal disconnect and offers a comprehensive review of statistical design and methodology commonly employed in this bench-to-bedside research. Documents Alternative Research Approaches for Faster and More Accurate Data Judgment Calls Elaborating on how to introduce TM into clinical studies, this authoritative work presents a keen approach to building, executing, and validating statistical models that consider data from various phases of development. It also delineates a truly translational example to help bolster understanding of discussed concepts. This comprehensive guide effectively demonstrates how to overcome obstacles related to successful TM practice. It contains invaluable information for pharmaceutical scientists, research executives, clinicians, and biostatisticians looking to expedite successful implementation of this important process.


Author: Information Resources Management Association
Publsiher: IGI Global
Total Pages: 1246
Release: 2013-03-31
ISBN 10: 146663605X
ISBN 13: 9781466636057
Language: EN, FR, DE, ES & NL

Bioinformatics Book Review:

"Bioinformatics: Concepts, Methodologies, Tools, and Applications highlights the area of bioinformatics and its impact over the medical community with its innovations that change how we recognize and care for illnesses"--Provided by publisher.

Medicine for MRCP

Medicine for MRCP
Author: Rupa Bessant
Publsiher: Oxford Specialty Training: Revision Texts
Total Pages: 944
Release: 2020-03-23
ISBN 10: 019877950X
ISBN 13: 9780198779506
Language: EN, FR, DE, ES & NL

Medicine for MRCP Book Review:

Medicine for MRCP provides a comprehensive review of the material that you need to pass the MRCP Parts 1 and 2 written papers. The twenty-seven chapters mapped out to the RCP syllabus, cover all areas from molecular medicine and genetics, through to medical law and ethics. Written by specialist contributors and educational experts, the content is carefully crafted to build your understanding for both papers. Each chapter begins with the basic science required for Part 1, before covering clinical medicine for Part 1, Part 2 and the PACES examinations. To ensure effective revision, material is presented in short sections with bullet lists, tables, and boxes. Over 150 drawings and photos illustrate key principles and clinical topics making them easier to retain. References to evidence-based protocols and directions to further reading allow for deeper understanding. Candidates can review their progress via the 180 end-of chapter self-assessment questions. Drawing on the authors' expertise, Medicine for MRCP is the ideal companion for the MRCP as well as a useful reference guide for practicing medical doctors.

Translational Research in Breast Cancer

Translational Research in Breast Cancer
Author: Dong-Young Noh,Wonshik Han,Masakazu Toi
Publsiher: Springer Nature
Total Pages: 630
Release: 2021-05-13
ISBN 10: 9813296208
ISBN 13: 9789813296206
Language: EN, FR, DE, ES & NL

Translational Research in Breast Cancer Book Review:

This book describes recent advances in translational research in breast cancer and presents emerging applications of this research that promise to have meaningful impacts on diagnosis and treatment. It introduces ideas and materials derived from the clinic that have been brought to "the bench" for basic research, as well as findings that have been applied back to "the bedside". Detailed attention is devoted to breast cancer biology and cell signaling pathways and to cancer stem cell and tumor heterogeneity in breast cancer. Various patient-derived research models are discussed, and a further focus is the role of biomarkers in precision medicine for breast cancer patients. Next-generation clinical research receives detailed attention, addressing the increasingly important role of big data in breast cancer research and a wide range of other emerging developments. An entire section is also devoted to the management of women with high-risk breast cancer. Translational Research in Breast Cancer will help clinicians and scientists to optimize their collaboration in order to achieve the common goal of conquering breast cancer.

AIA Academy Journal

AIA Academy Journal
Author: Academy of Architecture for Health
Total Pages: 135
Release: 2022
ISBN 10: 1312066636
ISBN 13: 9781312066632
Language: EN, FR, DE, ES & NL

AIA Academy Journal Book Review:

Biomaterials in Translational Medicine

Biomaterials in Translational Medicine
Author: Lei Yang,Sarit Bhaduri,Thomas J. Webster
Publsiher: Academic Press
Total Pages: 358
Release: 2018-11-30
ISBN 10: 012813478X
ISBN 13: 9780128134788
Language: EN, FR, DE, ES & NL

Biomaterials in Translational Medicine Book Review:

Biomaterials in Translational Medicine delivers timely and detailed information on the latest advances in biomaterials and their role and impact in translational medicine. Key topics addressed include the properties and functions of these materials and how they might be applied for clinical diagnosis and treatment. Particular emphasis is placed on basic fundamentals, biomaterial formulations, design principles, fabrication techniques and transitioning bench-to-bed clinical applications. The book is an essential reference resource for researchers, clinicians, materials scientists, engineers and anyone involved in the future development of innovative biomaterials that drive advancement in translational medicine. Systematically introduces the fundamental principles, rationales and methodologies of creating or improving biomaterials in the context of translational medicine Includes the translational or commercialization status of these new biomaterials Provides the reader with enough background knowledge for a fundamental grip of the difficulties and technicalities of using biomaterial translational medicine Directs the reader on how to find other up-to-date sources (i.e. peer reviewed journals) in the field of translational medicine and biomaterials

How Translational Medicine Is Progressively Redefining Healthcare

How Translational Medicine Is Progressively Redefining Healthcare
Author: Fritz Dufour, MBA, DESS
Publsiher: Fritz Dufour
Total Pages: 23
Release: 2017-12-19
ISBN 10: 1928374650XXX
ISBN 13: 9182736450XXX
Language: EN, FR, DE, ES & NL

How Translational Medicine Is Progressively Redefining Healthcare Book Review:

The preliminary idea behind translational medicine, conducting biological research to treat diseases, is not a new concept. But, scientists have been serious about placing the patient at all levels of the research process – right at the basic science level phase and all the way to the bedside – since only the 1990s. Today, translational research is a scientific field, although multidisciplinary. That innovation stemmed from the discoveries of new diseases and new technologies that allow healthcare professionals to have new perspectives on how to better and more efficiently treat patients. Translational medicine is viable, and it has already proved itself in many areas. Normally, every great discovery or innovation comes with both rewards and challenges, and continuous improvement is what keeps it alive. Translational research, an innovative concept, is not impervious to that rule. This paper examines the antecedents of translational medicine and how it came about. It considers the importance of incorporating basic science, applied science or clinical research, and the patient at every turn of the processes by analyzing the importance of translational research and its direct applications. On the other hand, this paper considers the challenges faced by translational medicine in an age where healthcare costs are skyrocketing, and suggests what can be done to circumvent the downsides. Finally, because the field is relatively new and promising, the discussion that follows also considers the outlook for translational medicine, and how important it is for scientists – artificial intelligence experts, computer, or bioengineers, healthcare professionals and healthcare management professionals – to lay right now the groundwork for future generations.

Translational Medicine in CNS Drug Development

Translational Medicine in CNS Drug Development
Author: George G. Nomikos,Douglas E. Feltner
Publsiher: Academic Press
Total Pages: 458
Release: 2019-06-18
ISBN 10: 0128031646
ISBN 13: 9780128031643
Language: EN, FR, DE, ES & NL

Translational Medicine in CNS Drug Development Book Review:

Translational Medicine in CNS Drug Development, Volume 29, is the first book of its kind to offer a comprehensive overview of the latest developments in translational medicine and biomarker techniques. With extensive coverage on all aspects of biomarkers and personalized medicine, and numerous chapters devoted to the best strategies for developing drugs that target specific disorders, this book presents an essential reference for researchers in neuroscience and pharmacology who need the most up-to-date techniques for the successful development of drugs to treat central nervous system disorders. Despite increases in the number of individuals suffering from CNS-related disorders, the development and approval of drugs for their treatment have been hampered by inefficiencies in advancing compounds from preclinical discovery to the clinic. However, in the past decades, game-changing strides have been made in our understanding of the pathophysiology of CNS disorders and the relationship of drug exposure in plasma and CNS to pharmacodynamic measures in both animals and humans. Includes comprehensive coverage of biomarker tools and the role of personalized medicine in CNS drug development Discusses strategies for drug development for a full range of CNS indications, with particular attention to neuropsychiatric and neurocognitive disorders Includes chapters written by international experts from industry and academia